TORONTO--Tm Bioscience here, which designs, develops, and commercializes DNA products for bioinformatics, functional genomics, and other uses, has auth orized the issuance of an additional 340,000 stock purchase op tions, subject to approval by the Vancouver Stock Exchange. The options vest over four years and expire on August 26, 2001. They have been awarded to recently appointed executives and employees.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.